![Mr Marcus Cumberbatch , [object Object]](/_next/image?url=https%3A%2F%2Fd3fzwscyjtgllx.cloudfront.net%2Fuploads%2Fimages%2F1992717150669980364964.jpg&w=3840&q=60)
Consultant urological surgeon
Consults at:
Mr Marcus Cumberbatch is a leading Consultant Urological Surgeon based in Sheffield and Nottingham, who specialises in Prostate Cancer, Prostate Biopsy and Bladder Problems alongside Bladder Cancer, Benign Prostate Disease and Diagnostic Treatment. He privately practises at The Thornbury Hospital, Spire Hospital Claremont and The Park Hospital, while his NHS base is Royal Hallamshire Hospital. He is also a Senior Clinical Lecturer at the University of Sheffield.
Mr Cumberbatch has an impressive educational CV, with an MBBS from University College London and MRCS from the Royal College of Surgeons of England. As part of his medical school training, Mr Cumberbatch attended the Welcome Institute where he obtained a scholarship to complete an Intercalated BSc in the History of Medicine.
Further educational achievements include foundation training in the Nottingham Deanery, the Academic Clinical Fellowship and a PhD in Cancer Biology. He was also awarded an Academic Clinical Lectureship by the National Institute for Health Research (NIHR) and was granted the Ellison-Cliffe Foundation Award by the Royal Society of Medicine (RSM) where he learnt about Robot-assisted Surgery and Novel Cancer Diagnostics in Melbourne, Australia.
Mr Cumberbatch is highly respected among his peers, and he has presented at various international conferences in countries including Japan, Spain and Denmark. He holds several leadership positions including Principal Investigator on a number of NIHR portfolio clinical trials investigating the use of Robotics in Minimally-Invasive Surgery, Patient Outcome Meetings and Cancer Screening.
His clinical research has featured in a selection of peer-reviewed journals, and he has an international reputation for his cancer epidemiology knowledge. Mr Cumberbatch is a member of various professional organisations, including the European Association of Urology (EAU) and the Medical Defence Union (MDU). Furthermore, he's a Fellow of the Royal College of Surgeons of Edinburgh.
In 2021, Mr Cumberbatch published an international multicentre series showing that Robotic Surgery can be used even in high-risk situations where kidney function is poor or only one kidney is present. These patients previously may have been facing open surgery or lifelong dialysis, but with robotic techniques can now be offered a keyhole operation to remove the cancer with less complications, fast recovery times and improved outcomes.
